HealthDay - WEDNESDAY, July 11 (HealthDay News) -- A study in rats suggests thatthe anti-obesity drug rimonabant may also reduce liver damage and improvecholesterol levels.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.